|Articles|January 20, 2015

Study finds children with residual amblyopia did not find an advantage with levodopa

A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA.

Baltimore-A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA. 

 

Read the results of the study here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.


Latest CME